Verve Therapeutics, Inc. Quarterly Operating Lease, Liability in USD from Q3 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Verve Therapeutics, Inc. quarterly Operating Lease, Liability history and growth rate from Q3 2021 to Q2 2024.
  • Verve Therapeutics, Inc. Operating Lease, Liability for the quarter ending June 30, 2024 was $72.5M, a 6.92% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $72.5M -$5.39M -6.92% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $73.7M -$6.44M -8.04% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $74.9M -$7.01M -8.56% Dec 31, 2023 10-K 2024-02-27
Q3 2023 $76.8M -$3.39M -4.23% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $77.9M -$30.2M -28% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $80.1M -$28.8M -26.4% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $81.9M -$26.8M -24.7% Dec 31, 2022 10-K 2023-03-02
Q3 2022 $80.2M -$28.6M -26.3% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $108M Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $109M Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $109M Dec 31, 2021 10-K 2022-03-14
Q3 2021 $109M Sep 30, 2021 10-Q 2021-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.